title: Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients.
abstract: The blockade of muscarinic receptors in the management of overactive bladder (OAB) symptoms provides beneficial as well as adverse effects. The cognitive changes observed are caused by the drugs' ability to cross the blood-brain barrier and bind to muscarinic receptors within the central nervous system (CNS). To date, while not specifically testing for CNS side effects, most of the controlled efficacy trials of multiple OAB medications have not shown significant adverse effects on cognitive function. However, elderly individuals, in whom OAB is more prevalent, often are excluded from these studies. The few trials that have performed cognitive testing in healthy elderly people taking antimuscarinics have clearly shown that oxybutynin can adversely affect cognition. Darifenacin, trospium, solifenacin, and tolterodine appear to have little to no risk of causing CNS side effects in this population. However, caution needs to be used in elderly patients with preexisting dementia.
authors: Department of Urology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA.
authors: Dustin
authors: D
authors: Pagoria
authors: R Corey
authors: RC
authors: O'Connor
authors: Michael L
authors: ML
authors: Guralnick
references: Br J Clin Pharmacol. 2011 Aug;72(2):235-46
references: 21392072
references: BJU Int. 2007 Nov;100(5):987-1006
references: 17922784
references: J Am Geriatr Soc. 2008 May;56(5):847-53
references: 18384584
references: Clin Pharmacol Ther. 2004 May;75(5):484-8
references: 15116061
references: Nat Rev Neurosci. 2006 Jan;7(1):41-53
references: 16371949
references: Clin Drug Investig. 2006;26(10):603-6
references: 17163294
references: Br J Clin Pharmacol. 2004 Jan;57(1):6-14
references: 14678335
references: PLoS One. 2011 Feb 23;6(2):e16718
references: 21373193
references: BMJ. 2006 Feb 25;332(7539):455-9
references: 16452102
references: Am J Obstet Gynecol. 2007 Aug;197(2):e8
references: 17689620
references: Urology. 2004 Dec;64(6 Suppl 1):2-6
references: 15621220
references: Int J Clin Pract. 2010 Aug;64(9):1279-86
references: 20529135
references: J Urol. 2005 Feb;173(2):493-8
references: 15643227
references: Eur Urol. 2005 Sep;48(3):471-7
references: 15990219
references: J Am Geriatr Soc. 1998 Jan;46(1):8-13
references: 9434659
references: Eur Urol. 2003 Jan;43(1):1-5
references: 12507537
references: Urology. 2010 Dec;76(6):1350-7
references: 20974482
references: Clin Ther. 2005 Jan;27(1):127-38; quiz 139-40
references: 15763613
references: BJU Int. 2011 Feb;107(4):612-20
references: 20707790
references: Arch Neurol. 2003 May;60(5):771-3
references: 12756144
references: J Am Geriatr Soc. 2010 Aug;58(8):1618-9
references: 20942892
references: BJU Int. 2005 Feb;95(3):346-9
references: 15679791
references: Curr Med Res Opin. 2007 Oct;23(10):2347-58
references: 17706004
references: BJU Int. 2008 Apr;101(8):1036-42
references: 18279452
references: BJU Int. 2005 Nov;96(7):1055-62
references: 16225528
references: J Clin Pharmacol. 2001 Jun;41(6):636-44
references: 11402632
references: Am J Geriatr Pharmacother. 2006 Mar;4(1):14-24
references: 16730617
references: Expert Opin Pharmacother. 2008 Jul;9(10):1787-96
references: 18570610
references: N Engl J Med. 2003 Dec 4;349(23):2274-5
references: 14657444
references: Curr Urol Rep. 2004 Dec;5(6):423-6
references: 15541209
references: J Am Geriatr Soc. 2002 Jun;50(6):1165-6
references: 12110086
references: J Am Geriatr Soc. 2005 Dec;53(12):2195-201
references: 16398909
references: Eur J Clin Pharmacol. 1994;47(4):337-43
references: 7875185
references: J R Soc Med. 2000 Sep;93(9):457-62
references: 11089480
references: Psychiatr Serv. 2004 Nov;55(11):1318-9
references: 15534031
references: J Clin Pharm Ther. 1998 Aug;23(4):247-55
references: 9867310
references: Am J Med. 2006 Mar;119(3 Suppl 1):9-15
references: 16483863
references: J Gerontol. 1983 Jan;38(1):31-5
references: 6129272
references: Drugs Aging. 2011 Feb 1;28(2):151-60
references: 21275440
references: World J Urol. 2003 May;20(6):327-36
references: 12811491
references: BJU Int. 2004 Feb;93(3):303-10
references: 14764127
references: Int J Clin Pract. 2008 Nov;62(11):1792-800
references: 18699842
references: Int J Clin Pract. 2010 Aug;64(9):1294-300
references: 20561092
references: Drug Metab Dispos. 2009 Jul;37(7):1371-4
references: 19389858
references: Drugs Aging. 1993 Jul-Aug;3(4):335-48
references: 8369593
references: Urology. 2002 Oct;60(4):719-25
references: 12385950
references: Eur Urol. 2006 Aug;50(2):317-26
references: 16687205
references: BJU Int. 2008 Nov;102(9):1128-32
references: 18647298